Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer

Jing Shi1, Demao Yao, Wei Liu

  • 1Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, the People's Republic of China.

BMC Cancer
|February 2, 2012
PubMed
Abstract

Insights

PIK3CA amplification is common in gastric cancer, unlike mutations, and is linked to poorer patient survival. This suggests the PI3K/Akt pathway is a potential therapeutic target for gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The phosphoinositide 3-kinase (PI3K)/Akt pathway is crucial for cell growth and survival in cancers, including gastric cancer.
  • PIK3CA mutations and amplification frequently activate this pathway in various human cancers.
  • Previous research lacked comprehensive analysis of PIK3CA alterations and their impact on gastric cancer patient outcomes.

Purpose of the Study:

  • To investigate the prevalence of PIK3CA mutations and amplification in gastric cancer.
  • To determine the association between PIK3CA alterations and clinicopathological features.
  • To evaluate the prognostic significance of PIK3CA amplification in gastric cancer patients.

Main Methods:

  • Direct sequencing was used to detect PIK3CA mutations.
  • Real-time quantitative PCR assessed PIK3CA amplification.
  • Kaplan-Meier survival analysis correlated PIK3CA status with patient outcomes.

Main Results:

  • PIK3CA mutations occurred in 7.1% of patients, while amplification was found in 67%.
  • PIK3CA amplification correlated with increased phosphorylated Akt (p-Akt) levels and cancer-related death.
  • Patients with PIK3CA amplification exhibited significantly shorter survival times.

Conclusions:

  • PIK3CA amplification is a frequent event in gastric cancer, unlike mutations, and is a key driver of PI3K/Akt pathway activation.
  • PIK3CA amplification serves as a significant negative prognostic marker for gastric cancer patients.
  • Targeting the PI3K/Akt signaling pathway presents a promising therapeutic strategy for gastric cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...